+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of the hyperhomocysteinemia and coagulation-fibrinolytic system activity status in vascular access thrombosis in hemodialysis patients



Role of the hyperhomocysteinemia and coagulation-fibrinolytic system activity status in vascular access thrombosis in hemodialysis patients



Nephrology Dialysis Transplantation 15(9): A190




(PDF emailed within 1 workday: $29.90)

Accession: 035683722

Download citation: RISBibTeXText


Related references

Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney International 55(1): 315-320, 1999

Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study. Vascular Health and Risk Management 9: 361-364, 2013

Hyperhomocysteinemia and vascular access thrombosis in chronic hemodialysis Is there an association?. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 282A, 2000

No association between hyperhomocysteinemia and vascular access thrombosis in chronic hemodialysis. Journal of Vascular Access 4(1): 14-20, 2003

Role of Genetic Factors in Vascular Access Thrombosis in Hemodialysis Patients. Hemodialysis International 8(1): 81-82, 2004

Role of thrombophilia in vascular access thrombosis among chronic hemodialysis patients in Tunisia. Therapeutic Apheresis and Dialysis 15(1): 40-43, 2011

Imbalance of coagulation and fibrinolysis can predict vascular access failure in patients on hemodialysis after vascular access intervention. Journal of Vascular Surgery 2018, 2018

Role of genetic mutations in vascular access thrombosis among hemodialysis patients waiting for renal transplantation. Transplantation Proceedings 34(6): 2030-2032, 2002

The role of coagulation fibrinolytic system in diabetic vascular complications 1. urine factor excretion in diabetics and its role in the intra glomerular coagulation. Acta Haematologica Japonica 43(4): 715-722, 1980

The role of coagulation-fibrinolytic system in diabetic vascular complications. Part 1: Urine factor excretion in diabetics and its role in the intraglomerular coagulation. Nihon Ketsueki Gakkai Zasshi 43(4): 715-722, 1980

Hyperhomocysteinemia and levels of lipoprotein are inversely related to failure of vascular access in patients on maintenance hemodialysis. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 252A-253A, Sept, 1997

Thombotic events in vascular access of hemodialysis patients and the correlation with hyperhomocysteinemia, lipids and oxidative stress. Nephrology Dialysis Transplantation 17(Abstracts Supplement 1): 284, 2002

The role of coagulation-fibrinolytic system in diabetic vascular complications. Part II: Involvement of coagulation-fibrinolytic system in diabetic vascular complications. Nihon Ketsueki Gakkai Zasshi 43(4): 723-729, 1980

The role of endothelial nitric oxide synthase gene G894T and intron 4 VNTR polymorphisms in hemodialysis patients with vascular access thrombosis. Anadolu Kardiyoloji Dergisi 14(3): 239-243, 2015

Mutation at ARG-506 of coagulation factor V and access thrombosis in hemodialysis patients. Journal of the American Society of Nephrology 6(3): 503, 1995